Population pharmacokinetic analysisof lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART

被引：0
|
作者：
Xavière Panhard
Mayeule Legrand
Anne-Marie Taburet
Bertrand Diquet
Cécile Goujard
France Mentré
机构：
[1] INSERM U738,INSERM U738; UF de Biostatistiques
[2] AP-HP,UFR de Médecine
[3] Hôpital Bichat,Département de Pharmacologie Clinique
[4] Université Paris 7 Denis Diderot,Service de Pharmacie Clinique
[5] AP-HP,Service de Pharmacologie Clinique et Toxicologie
[6] Hôpital La Pitié-Salpétrière,Service de Médecine Interne
[7] AP-HP,undefined
[8] Hôpital Bicêtre,undefined
[9] CHU ANGERS,undefined
[10] AP-HP,undefined
[11] Hôpital Bicêtre,undefined
来源：
European Journal of Clinical Pharmacology | 2007年 / 63卷
关键词：
Nucleoside analogs; Drug-drug interactions; Population pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1019 / 1029
页数：10
相关论文
共 50 条
  • [41] Quality of life and adherence to HAART in HIV-infected patients
    Geocze, Luciana
    Mucci, Samantha
    De Marco, Mario Alfredo
    Nogueira-Martins, Luiz Antonio
    Citero, Vanessa de Albuquerque
    [J]. REVISTA DE SAUDE PUBLICA, 2010, 44 (04): : 743 - 749
  • [42] Reduced dose of stavudine and lipoatrophy in HIV-infected patients in Cameroon
    Cournil, Amandine
    Coudray, Mathilde
    Kouanfack, Charles
    Essomba, Claudine Ntsama
    Tonfack, Clement Auguste Djouatsa
    Biwole-Sida, Magloire
    Delaporte, Eric
    Bork, Kirsten
    Laurent, Christian
    [J]. ANTIVIRAL THERAPY, 2010, 15 (07) : 1039 - 1043
  • [43] HAART-related nephropathies in HIV-infected patients
    Daugas, E
    Rougier, JP
    Hill, G
    [J]. KIDNEY INTERNATIONAL, 2005, 67 (02) : 393 - 403
  • [44] Peripheral neuropathies in HIV-infected patients in the era of HAART
    Authier, FJ
    Gheradi, RK
    [J]. BRAIN PATHOLOGY, 2003, 13 (02) : 223 - 228
  • [45] Hospital admissions for HIV-infected patients in the era of HAART
    Manavi, K.
    [J]. HIV MEDICINE, 2010, 11 : 62 - 62
  • [46] Pharmacokinetic characteristics of ritonavir, zidovudine, lamivudine, and stavudine in children with human immunodeficiency virus infection
    Fletcher, CV
    Yogev, R
    Nachman, SA
    Wiznia, A
    Pelton, S
    McIntosh, K
    Stanley, K
    [J]. PHARMACOTHERAPY, 2004, 24 (04): : 453 - 459
  • [47] The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience
    Erhabor, Osaro
    Ejele, O. A.
    Nwauche, C. A.
    [J]. RETROVIROLOGY, 2009, 6
  • [48] The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience
    Osaro Erhabor
    OA Ejele
    CA Nwauche
    [J]. Retrovirology, 6
  • [49] Adherence, side effects and efficacy of stavudine plus lamivudine plus nelfinavir in treatment-experienced HIV-infected patients
    Roca, B
    Gómez, CJ
    Arnedo, A
    [J]. JOURNAL OF INFECTION, 2000, 41 (01) : 50 - 54
  • [50] Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults - A randomized equivalence trial
    Staszewski, S
    Keiser, P
    Montaner, J
    Raffi, F
    Gathe, J
    Brotas, V
    Hicks, C
    Hammer, SM
    Cooper, D
    Johnson, M
    Tortell, S
    Cutrell, A
    Thorborn, D
    Isaacs, R
    Hetherington, S
    Steel, H
    Spreen, W
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (09): : 1155 - 1163
12345